Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 16;72(4):443-460.
doi: 10.33073/pjm-2023-042. eCollection 2023 Dec 1.

The Potential Role of Pyrroloquinoline Quinone to Regulate Thyroid Function and Gut Microbiota Composition of Graves' Disease in Mice

Affiliations

The Potential Role of Pyrroloquinoline Quinone to Regulate Thyroid Function and Gut Microbiota Composition of Graves' Disease in Mice

Xiaoyan Liu et al. Pol J Microbiol. .

Abstract

Graves' disease (GD) is an autoimmune disorder disease, and its prevalence continues to increase worldwide. Pyrroloquinoline quinone (PQQ) is a naturally antioxidant compound in milk, vegetables, and meat. We aim to identify the treatment efficacy of PQQ on GD and its regulatory effect on intestinal microbiota. The GD mice model was built by an adenovirus expressing autoantigen thyroid-stimulating hormone receptor (Ad-TSHR289). Fecal samples were collected for 16S rDNA sequencing after PQQ pretreatments (20, 40, or 60 mg/kg BW/day) for 4 weeks. Thyroid and intestine functions were measured. The levels of serum TSHR and T4 were significantly raised, and the thyroid gland size was typically enlarged in the GD group than in controls, reversed by PQQ therapy. After PQQ replenishment, IL6 and TNFα levels in small intestine tissues were lower than those in the GD group, with Nrf2 and HO1 levels improved. Also, the PQQ supplement could maintain the mucosal epithelial barrier impaired by GD. In microbial analyses, PQQ treatment could prompt the diversity recovery of gut microbiota and reconstruct the microbiota composition injured by GD. Lactobacillus served as the most abundant genus in all groups, and the abundance of Lactobacillus was increased in the GD group than in control and PQQ groups. Besides, Lactobacillus was highly correlative with all samples and the top 50 genera. PQQ supplementation regulates thyroid function and relieves intestine injury. PQQ changes the primary composition and abundance of GD's intestine microbiota by moderating Lactobacillus, which may exert in the pathogenesis and progression of GD.

Keywords: Graves’ disease; Lactobacillus; gut microbiota; pyrroloquinoline quinone; thyroid function.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors do not report any financial or personal connections with other persons or organizations, which might negatively affect the contents of this publication and/or claim authorship rights to this publication.

Figures

Fig. 1.
Fig. 1.
PQQ supplement modulates thyroid function and ameliorates thyroid injury. A) The concentrations of T4 and B) TRAb levels were determined inserum samples using Mouse ELISA Kit, C) the representative pictures of H&E staining of thyroids (200 × magnification with 100 μm of scale). Data were represented as mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001 between groups. Con – control group, GD – Graves’ disease group, GD + PQQ/low – GD mice treated with 20 mg PQQ/kg BW/day, GD + PQQ/mid – GD mice treated with 40 mg PQQ/kg BW/day, GD + PQQ/high – GD mice treated with 60 mg PQQ/kg BW/day, GD + MMI – GD mice treated with 2.5 mg MMI/kg/BW/day, PQQ – pyrroloquinoline quinone, MMI – methimazole
Fig. 2.
Fig. 2.
PQQ supplement decreases inflammation and oxidative stress response and alleviates small intestine epithelial injury. Relative expression of mRNA in colons of A) IL6, TNFα, B) Nrf2, HO1 was detected by PCR, C) the representative pictures of the hematoxylin and eosin (H&E) staining of colons (200 × magnification with 100 μm of scale). Data are represented as mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.001 between groups
Fig. 3.
Fig. 3.
Oral gavage of PQQ restores the diversity of gut microbiota in the GD group. A) Rank-abundance curves of the gut microbiota at the OTU level, B) rarefaction curves (SOBs index) of the gut microbiota at the OTU level. Comparison of a diversity in C) Sobs, D) Ace, E) Chao indices in Con, GD and PQQ/mid groups at the OTU level. Analysis of β diversity using F) PCA, G) PCoA based on bray_curtis, H) binary_jaccard and I) unweighted_unifrac distance and J) NMDS on the genus level. **p < 0.01; ***p < 0.001. OTUs – operational taxonomic units, PCA – principal component analysis, PCoA – principal coordinate analysis, NMDS – non-metric multidimensional scaling
Fig. 4.
Fig. 4.
PQQ alters the composition and abundance of intestine flora in the GD group. A) The species Venn diagram at the genus level. Overlapping parts in the figure indicate common species. On the genus level, percent of community abundance unique to B) the Con group, C) GD group and E) PQQ group. D) Percent of community abundance shared by 3 groups.
Fig. 4.
Fig. 4.
PQQ alters the composition and abundance of intestine flora in the GD group. F) Percent of community abundance of 3 groups on the Phylum level. G) Percent of community abundance of 3 groups on the Genus level. On the genus level, percent of community abundance in H) the Con group, I) GD group and J) PQQ group.
Fig. 4.
Fig. 4.
PQQ alters the composition and abundance of intestine flora in the GD group. I) GD group and J) PQQ group. K) The heatmap on the abundance of top 30 genera among 3 groups. L) The Circos analysis of the abundance association between the sample and the top 10 genera.
Fig. 5.
Fig. 5.
Spearman correlation analysis and PICRUSt prediction under PQQ supplement in the GD group. A) Kruskal-Wallis H test validated the differential distributed genera and C) the abundance of Lactobacillus among all 3 groups. B) LEfSe analysis showed that the relative abundance of 14 genera was significantly different among all groups (LDA score > 3.0 or < –3.0, p < 0.05). LEfSe – linear discriminant analysis effect size, LDA – linear discriminant analysis, KEGG – Kyoto Encyclopedia of Genes and Genomes, COG – Clusters of Orthologous Groups, RDA – redundancy analysis
Fig. 5.
Fig. 5.
Spearman correlation analysis and PICRUSt prediction under PQQ supplement in the GD group. D) The Heatmap of KEGG pathway, and E) the COG functional abundance box distribution based on the PICRUSt prediction among 3 groups. LEfSe – linear discriminant analysis effect size, LDA – linear discriminant analysis, KEGG – Kyoto Encyclopedia of Genes and Genomes, COG – Clusters of Orthologous Groups, RDA – redundancy analysis
Fig. 5.
Fig. 5.
Spearman correlation analysis and PICRUSt prediction under PQQ supplement in the GD group. D) The Heatmap of KEGG pathway, and E) the COG functional abundance box distribution based on the PICRUSt prediction among 3 groups. F) RDA results of gut microbiota and environmental factors (T4, TRAB, IL6, TNFα, Nrf2 and HO1) of mice in 3 groups. G) Network Diagram based on the Collinearity Analysis in 3 groups. LEfSe – linear discriminant analysis effect size, LDA – linear discriminant analysis, KEGG – Kyoto Encyclopedia of Genes and Genomes, COG – Clusters of Orthologous Groups, RDA – redundancy analysis
Fig. 5.
Fig. 5.
Spearman correlation analysis and PICRUSt prediction under PQQ supplement in the GD group. H) Spearman Correlation Analysis between samples and top 50 genera. LEfSe – linear discriminant analysis effect size, LDA – linear discriminant analysis, KEGG – Kyoto Encyclopedia of Genes and Genomes, COG – Clusters of Orthologous Groups, RDA – redundancy analysis
None
None
None

References

    1. Aldars-García L, Chaparro M, Gisbert JP Systematic review: the gut microbiome and its potential clinical application in inflammatory bowel disease Microorganisms 2021 NaN9(5):977. doi: 10.3390/microorganisms9050977. . . . ; ( ): . https://doi.org/ - DOI - PMC - PubMed
    1. Arrieta MC, Stiemsma LT, Dimitriu PA, Thorson L, Russell S, Yurist-Doutsch S, Kuzeljevic B, Gold MJ, Britton HM, Lefebvre DL, et al Early infancy microbial and metabolic alterations affect risk of childhood asthma Sci Transl Med 2015 NaN7(307):307ra152 doi: 10.1126/scitranslmed.aab2271. . . . ; ( ): . https://doi.org/ - DOI - PubMed
    1. Assimakopoulos SF, Triantos C, Maroulis I, Gogos C the role of the gut barrier function in health and disease Gastroenterology Res 2018 NaN11(4):261. doi: 10.14740/gr1053w. . . . ; ( ): –. . https://doi.org/ - DOI - PMC - PubMed
    1. Bunyavanich S, Shen N, Grishin A, Wood R, Burs W, Dawson P, Jones SM, Leung DYM, Sampson H, Sicherer S, et al Early-life gut microbiome composition and milk allergy resolution J Allergy Clin Immunol 2016 NaN138(4):1122. doi: 10.1016/j.jaci.2016.03.041. . . . ; ( ): –. . https://doi.org/ - DOI - PMC - PubMed
    1. Davies TF, Andersen S, Latif R, Nagayama Y, Barbesino G, Brito M, Eckstein AK, Stagnaro-Green A, Kahaly GJ Graves’ disease Nat Rev Dis Primers 2020 NaN6(1):52. doi: 10.1038/s41572-020-0184-y. . . . ; ( ): . https://doi.org/ - DOI - PubMed

LinkOut - more resources